{
  "cui": "C4545381",
  "cui_name": "Myeloid and/or lymphoid neoplasm associated with platelet derived growth factor receptor alpha rearrangement",
  "incidence_per_100k": 0.2,
  "prevalence_per_100k": null,
  "metric_type": "incidence",
  "total_cases_per_year": 16000,
  "confidence": 0.55,
  "is_subtype": true,
  "parent_disease": "Myeloid and lymphoid neoplasm",
  "reasoning": "PDGFRA-rearranged neoplasms include eosinophilia-associated disorders and other rare myeloid/lymphoid malignancies. Estimated incidence ~0.2 per 100k based on WHO classification data and reported case frequencies.",
  "data_quality": "moderate",
  "geographic_variation": "unknown",
  "year_specific": false,
  "data_year": null,
  "source": "WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues",
  "source_url": null,
  "source_type": "literature"
}